Amendment No. 1 to SHARE PURCHASE AGREEMENTShare Purchase Agreement • April 27th, 2018 • Sorrento Therapeutics, Inc. • Services-commercial physical & biological research
This Amendment No. 1 to Share Purchase Agreement (this “Amendment”) is effective as of April 27, 2018 by and among TNK Therapeutics, Inc., a Delaware corporation (the “Purchaser”), Sorrento Therapeutics, Inc., a Delaware corporation (“Sorrento”), and Dayspring Ventures Limited, a private limited company registered in Jersey under company number 75238 with address at 4 Bond Street, St Helier, Jersey JE2 3NP, as representative (the “Shareholders’ Representative”) of the shareholders (the “Shareholders”) of Virttu Biologics Limited (the “Company”).
